Chronic Kidney Disease Patient in Chronic Myloied Leukemia
NCT06266975 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2024-02-20
Summary
To study the Prevalence ,Characteristics and outcome of CKD in patiants with chronic myeloid leukemia .
Conditions
- Chronic Myeloid Leukemia in Remission
Interventions
- DEVICE
-
Biobsy from kidney
using tyrosine kinase inhibitors particulary imatinib in ttt CML patients
Sponsors & Collaborators
-
Sahar Mohammed Gad
lead OTHER
Principal Investigators
-
Ahmed Ramadan · Assist
-
Mohamed Ramadan · Assiut University
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-29
- Primary Completion
- 2026-11-30
- Completion
- 2026-11-30
More Related Trials
-
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
NCT07091019 ·Status: NOT_YET_RECRUITING
-
Study of Bone Marrow Samples From Patients With Acute Leukemia
NCT00897559 ·Status: COMPLETED
-
Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia
NCT01298414 ·Status: COMPLETED
-
Treatment of Chronic Lymphocytic Leukemia
NCT02757586 ·Status: UNKNOWN
-
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
NCT00004239 ·Status: TERMINATED ·Phase: PHASE1
-
Symptom Burden in Chronic Myeloid Leukemia (CML)
NCT01046305 ·Status: UNKNOWN
-
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia
NCT00898092 ·Status: UNKNOWN
-
Metabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI
NCT06121765 ·Status: NOT_YET_RECRUITING
-
Natural History Study of Patients With Chronic Myelogenous Leukemia
NCT00429910 ·Status: COMPLETED
-
S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy
NCT01360125 ·Status: COMPLETED
-
Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia
NCT01251159 ·Status: COMPLETED
-
Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia
NCT01247584 ·Status: COMPLETED
-
Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival Outcomes
NCT05057299 ·Status: COMPLETED
-
The Metabolic Syndrome Among Leukemia Survivors: Physiopathological Analysis
NCT02696304 ·Status: UNKNOWN ·Phase: NA
-
A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia
NCT02619604 ·Status: COMPLETED ·Phase: NA
-
Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia
NCT03881826 ·Status: COMPLETED ·Phase: NA
-
Studying Gene Expression in Tissue Samples From Young Patients With Acute Myeloid Leukemia
NCT01057303 ·Status: COMPLETED
-
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421
NCT01035307 ·Status: COMPLETED
-
Value of CD26 Positive Leukemic Stem Cell in Myeloproliferative Neoplasm
NCT04312607 ·Status: UNKNOWN
-
Biomarkers in Patients With Acute Myeloid Leukemia
NCT01138319 ·Status: COMPLETED
-
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
NCT01057290 ·Status: COMPLETED
-
Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia
NCT05893836 ·Status: COMPLETED
-
"Peripheral Blood Dipeptidylpeptidase IV (CD26) Positive Leukemic Stem Cells in Chronic Myeloid Leukemia as a Diagnostic Marker"
NCT05543161 ·Status: UNKNOWN
-
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
NCT01004640 ·Status: UNKNOWN
-
Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia
NCT01232842 ·Status: COMPLETED